Research output

Systematic Review and Network Meta-Analysis on the Efficacy of Evolocumab and Other Therapies for the Management of Lipid Levels in Hyperlipidemia

Research output: Contribution to journalReview articleAcademicpeer-review

Associated researcher

  • Toth, P. P.
  • Worthy, G.
  • Gandra, S. R.
  • Sattar, N.
  • Bray, S.
  • Cheng, L.
  • Bridges, I.
  • Worth, G. M.
  • Dent, R.
  • Forbes, C. A.
  • Deshpande, S.
  • Ross, J.
  • Kleijnen, J.M.P.

  • Stroes, E. S. G.

Associated organisations

    Research areas

  • alirocumab, evidence-based medicine, evolocumab, ezetimibe, lipids, low-density lipoprotein cholesterol, meta-analysis, proprotein convertase subtilisin/kexin type 9 inhibitor, statin therapy, HIGH CARDIOVASCULAR-RISK, SUBTILISIN/KEXIN TYPE 9, HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA, RANDOMIZED CONTROLLED-TRIAL, TREATED JAPANESE PATIENTS, ACUTE CORONARY SYNDROMES, ODYSSEY OPTIONS I, ISPOR TASK-FORCE, MONOCLONAL-ANTIBODY, STATIN THERAPY
View graph of relations


Original languageEnglish
Article numbere005367
Number of pages13
JournalJournal of the American Heart Association
Issue number10
Publication statusPublished - Oct 2017